Welcome to the Central Coast Sun

 fb yt

editor

editor

Publisher
Michael Walls
michael@accessnews.com.au
0407 783 413

Sunday, 02 April 2023 06:15

UPDATE: COAST ELECTION 2023

Crouch holds on, Labor romps in elsewhere
DALLAS SHERRINGHAM
MEMBER for Terrigal Adam Crouch has survived a weeklong battle with the ALP’s Sam Boughton to retain the seat despite a massive swing away from the former State LNP Government.
DALLAS SHERRINGHAM
MIKE Tyrrell is continuing the legacy created by his dad and uncle when they started their family first aid company, SURVIVAL on the Central Coast 35 years ago. 

STARTING April 1 PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) will be accessible on the Pharmaceutical Benefits Scheme (PBS) for mild to moderate COVID-19 patients aged between 60-69 with one extra risk factor for severe illness.

This change increases PAXLOVID's eligibility criteria, making it the only COVID-19 oral antiviral medication to receive such an expansion.

Pfizer's Medical Director for Australia and New Zealand, Dr Krishan Thiru, emphasised that this update would enable more at-risk Australians to get treatment from their homes if they test positive for COVID-19.

According to Infectious Diseases Specialist Professor Robert Booy of the University of Sydney, vaccination is the most effective way to protect against COVID-19, and PAXLOVID is suitable for those at high risk of severe disease.

Page 51 of 499

The Central Coast Sun covers the business and community issues of the NSW Central Coast region. The Central Coast Sun is a prime media source for connecting with the pulse of the region and tapping into it's vast opportunities.